Published online Sep 21, 2026. doi: 10.3748/wjg.118916
Revised: February 16, 2026
Accepted: March 10, 2026
Published online: September 21, 2026
Processing time: 219 Days and 16.3 Hours
Achalasia complicated by epiphrenic diverticulum presents a significant the
Core Tip: Management of achalasia with epiphrenic diverticulum is evolving. A one-size-fits-all septotomy is no longer justified. Intra-procedural endoscopic phenotyping allows for a selective approach: Division of a functionally obstructive muscular septum when present and standard myotomy alone when absent. This precision strategy, supported by recent meta-analytic data showing high treatment success for per-oral endoscopic myotomy in epiphrenic diverticula, achieves comparable outcomes to universal septotomy while minimizing overtreatment and its associated risks.
- Citation: Chisthi MM, Kuttanchettiyar KG, Viswanath S. One tunnel, two pathologies: Tailoring submucosal tunnelling per-oral endoscopic myotomy in achalasia with epiphrenic diverticulum by septum morphology. World J Gastroenterol 2026; 32(35): 118916
- URL: https://www.wjgnet.com/1007-9327/full/v32/i35/118916.htm
- DOI: https://dx.doi.org/10.3748/wjg.118916
This editorial refers to “Simultaneous treatment of concomitant achalasia coexisting with epiphrenic diverticulum: The practice of submucosal tunneling technique” by Hao et al, 2026; https://doi.org/10.3748/wjg.v32.i9.114758.
The paper from Hao et al[1] on the recent issue of World Journal of Gastroenterology describes the simultaneous treatment of con
Esophageal achalasia, the prototypical primary esophageal motility disorder, is characterized by absent peristalsis and failed relaxation of the lower esophageal sphincter (LES), leading to progressive dysphagia, regurgitation, and weight loss[2]. Its pathophysiology involves the selective loss of inhibitory neurons in the myenteric plexus. High-resolution manometry classifies achalasia into three subtypes, with type II demonstrating the most favorable response to interventions like POEM[3]. The global incidence ranges from 0.5 to 1 per 100000 person-years, with a peak in middle age, though pediatric cases are increasingly recognized and may represent a distinct clinical entity[4].
Epiphrenic diverticula (ED), saccular outpouchings within the distal 10 cm of the esophagus, complicate approximately 2%-10% of achalasia cases[5]. These are pulsion diverticula, formed by chronically elevated intraluminal pressure proximal to the non-relaxing LES. Their association with achalasia heightens the symptomatic burden and risk of complications like aspiration. The shared wall between the esophagus and the diverticulum, the septum, can hypertrophy into a prominent muscular band, creating a secondary point of obstruction and perpetuating a cycle of worsening pulsion. While POEM is established for achalasia, its application in the presence of ED creates a specific technical debate: Is routine septotomy always necessary, or can treatment be tailored based on septum morphology? The technical nuances of this dilemma have been further elucidated in the recent work by Hao et al[1], which describes the simultaneous treat
The historical standard for achalasia with ED involved open thoracic or Laparoscopic Heller myotomy (LHM) combined with diverticulectomy or diverticulopexy. While offering symptom relief in 70%-90% of cases, these procedures were burdened by significant morbidity: Anastomotic leaks (5%-15%), prolonged hospital stays, and persistent dysphagia in a notable minority[6,7]. Historically, isolated ED without an underlying motility disorder were managed with diverticulectomy alone, often via thoracotomy. However, when associated with achalasia, failure to address the underlying LES obstruction led to high recurrence rates (10%-15%) and persistent symptoms[7,8], underscoring the need for a combined approach addressing both pathologies. LHM with fundoplication improved the safety profile but still faced diverticular recurrence or symptomatic persistence in approximately 10%-15% of cases, necessitating re-intervention[7,8].
The introduction of POEM in 2010 fundamentally altered the landscape[9]. This minimally invasive, incision-less technique uses a submucosal tunnel to perform a myotomy, reporting technical success rates of 95%-100% and clinical success (Eckardt score ≤ 3) in 88%-95% of achalasia patients[10,11]. POEM’s efficacy spans all achalasia subtypes and is associated with shorter operative times and a favorable safety profile compared to LHM[11]. The 2024 SAGES guidelines issued a conditional recommendation endorsing either POEM (with appropriate proton pump inhibitor use) or LHM with fundoplication as first-line options, establishing POEM’s formal equivalence in modern clinical practice[12].
The study by Hao et al[1] represents an important contribution to the literature on endoscopic management of achalasia with ED. The authors demonstrate technical feasibility of simultaneous treatment using submucosal tunneling techniques, with successful outcomes in their cohort. However, several methodological considerations warrant careful examination.
First, the study's retrospective design and relatively small sample size limit the generalizability of its findings. While the technical success rate is encouraging, the lack of a comparison group receiving alternative approaches (e.g., standard POEM without septotomy) precludes definitive conclusions about the optimal management strategy. Second, the criteria for performing septotomy vs myotomy alone are not clearly defined in their methodology, highlighting the very knowledge gap that our proposed morphology-guided approach seeks to address.
Third, the study’s follow-up duration may be insufficient to fully capture delayed complications, particularly post-POEM gastroesophageal reflux disease (GERD), which can manifest asymptomatically and requires objective pH-impedance monitoring for detection[13,14]. Recent meta-analytic data by Kum et al[15] demonstrate that while early GERD rates are higher after POEM compared to Heller myotomy with fundoplication, this difference diminishes after 12 months, with comparable long-term GERD rates between approaches. This temporal pattern underscores the importance of extended follow-up in studies of POEM for complex achalasia.
Despite these limitations, Hao et al’s work[1] provides valuable proof-of-concept and aligns with the broader evidence supporting POEM for ED. Their experience reinforces the need for standardized protocols for intra-procedural decision-making—precisely the gap that our morphology-guided framework addresses.
The success of POEM for pure achalasia introduced a critical dilemma for the ED cohort: Is routine division of the diverticular septum always necessary? Advocates for universal septotomy argue it addresses a potential secondary obstruction. However, this adds complexity and may increase risks of mucosal perforation and extended myotomy length, potentially exacerbating post-procedural GERD[16]. Conversely, proponents of a selective approach contend that the primary pathology is the LES obstruction, and that septotomy should be reserved only for patients with a demonstrably obstructive septum visualized during the procedure.
This selective, anatomy-driven approach is grounded in growing evidence. A pivotal 2022 meta-analysis by Facciorusso et al[17] analyzed 300 patients with esophageal diverticula treated with POEM. For ED specifically, the pooled technical success rate was 95.1%, with a treatment success rate of 94.2% and a symptom recurrence rate of 0% in the analyzed cohort. This high efficacy, achieved without mandating universal septotomy, underscores that treating the underlying motility disorder is paramount. The strategy is simple: During POEM, the septum is endoscopically assessed. If a prominent, hypertrophied, obstructive muscular band is identified, septotomy is performed. If the diverticular opening is wide and non-obstructive, standard LES myotomy alone is completed. The key endoscopic distinction lies between a prominent, hypertrophied muscular septum that visibly bisects the lumen and requires division, and a wide-mouthed diverticular opening without a significant band, where a standard myotomy suffices. Recent international multicenter data from Shrigiriwar et al[18] further validate this selective approach, demonstrating comparable clinical outcomes between POEM with and without septotomy across diverse centers and operators.
While universally validated quantitative criteria (e.g., specific millimeter-based septum width or percentage of luminal occlusion) remain to be established, real-time endoscopic phenotyping relies on distinct morphological features to distinguish obstructive from non-obstructive septa[17,19].
An obstructive muscular septum is characterized endoscopically by: (1) Prominent ridge: A hypertrophied muscular band that projects conspicuously into the esophageal lumen, typically originating from the common wall between the esophagus and the diverticulum; (2) Luminal narrowing: Visible reduction in the cross-sectional area of the true esophageal lumen at the level of the diverticulum, often requiring gentle insufflation to appreciate the dynamic obstruction; (3) Functional partitioning: The septum acts as a secondary point of resistance, sometimes retaining food debris proximally despite an adequately relaxed LES; and (4) Septal height/width ratio: Although not standardized, an obstructive septum typically exhibits a height (depth of protrusion) that exceeds 50% of the adjacent esophageal luminal diameter, creating a palpable resistance during scope passage.
In contrast, a non-obstructive diverticulum demonstrates: (1) Wide mouth: A broad, patulous communication between the esophagus and the diverticular pouch without a significant intervening muscular ridge; and (2) Absence of luminal compromise: The true esophageal lumen remains widely patent, and the diverticulum appears as a passive outpouching rather than an active obstructing structure.
This morphology-driven distinction, while qualitative, has demonstrated clinical utility in guiding selective septotomy and achieving excellent outcomes[17,19]. Future directions include the application of artificial intelligence (AI)-based image analysis to standardize these criteria and reduce operator dependency.
The rationale for a morphology-guided POEM strategy becomes evident when comparing outcomes across treatment modalities. As summarized in Table 1, POEM-based approaches—whether performed with selective septotomy (88.9%-94.2% clinical success) or without septotomy (90.0%-94.2%)—achieve clinical success rates comparable to LHM with diverticulectomy (83.0%-90.0%)[6,17,20]. However, the minimally invasive nature of POEM confers significant advantages, including markedly shorter hospital stays (2.0-3.5 days vs 5-7 days for laparoscopic surgery and 8-10 days for open thoracotomy)[6,19,21].
| Treatment modality | Clinical success (%) | Hospital stays (day) | Notable adverse events | Key considerations |
| POEM with selective septotomy (ED + S) | 88.9-94.2[17,19] | 2.3-3.5[17] | Mucosal perforation (5%-15%)[17,22] | Minimally invasive; success hinges on accurate septum phenotyping |
| POEM without septotomy (ED - S) | 90.0-94.2[17,19] | 2.0-3.0[19] | Mucosal perforation (approximately 10%)[22] | Avoids septotomy-related risks; suitable for non-septated diverticula |
| Laparoscopic Heller myotomy + diverticulectomy | 83.0-90.0[6,20] | 5-7[1] | Anastomotic leak (5%-10%), recurrent diverticulum (10%-15%)[7,8] | Gold-standard surgery; allows concurrent fundoplication |
| Open transthoracic surgery | 70.0-85.0[21] | 8-10[21] | Pneumonia, leaks, prolonged recovery[21] | High morbidity; reserved for complex redo cases |
Importantly, the comparable outcomes between POEM with and without septotomy (88.9%-94.2% vs 90.0%-94.2%)[17,19] provide the foundational evidence for a selective approach. If universal septotomy were mandatory, one would expect inferior results when it is omitted. The equivalence of these outcomes instead suggests that septotomy is only necessary when a truly obstructive septum is present. This observation, combined with the potential to avoid septotomy-related complications such as mucosal perforation (5%-15% with septotomy vs approximately 10% without)[17,22], supports the clinical wisdom of a tailored strategy. These are depicted in Table 1.
Successful implementation requires careful endoscopic assessment. Pre-procedural imaging defines anatomy, but intra-procedural phenotyping is decisive. The principles of submucosal tunneling and secure mucosal closure remain paramount[22]. Long-term data shows durable symptom relief, with low rates of symptomatic recurrence or diverticular progression after POEM[23].
Post-POEM GERD is a well-managed sequela, occurring in 15%-30% of patients, typically responsive to proton pump inhibitors[13]. Long-term monitoring (beyond 6-12 months) is essential, as a substantial portion of post-POEM GERD is asymptomatic and identified only on routine pH-impedance studies[13,14]. For patients with large diverticula, combined POEM and diverticular POEM techniques have been successfully employed, as demonstrated by Wang et al[24] in a recent case report.
Based on current evidence, we advocate a four-step clinical framework for managing achalasia with epiphrenic diverticulum.
First, comprehensive diagnosis and staging are essential. High-resolution manometry confirms achalasia and identifies its subtype, which influences prognosis[3]. Concurrently, endoscopy and timed barium esophagogram characterize the diverticulum’s size, location, and morphology, providing baseline anatomical context[5].
Second, patient selection should prioritize POEM as a first-line option for most fit patients, given its high efficacy (88%-95%) and favorable safety profile[10-12]. However, surgery (LHM with diverticulectomy) remains relevant for giant diverticula (> 5 cm) or specific anatomical challenges such as dense prior submucosal fibrosis that precludes safe tunneling[6,7].
Third, intra-procedural decision-making represents the cornerstone of the morphology-guided approach as shown in Figure 1. During POEM, real-time endoscopic assessment of the diverticular septum determines the need for septotomy. As detailed in the preceding section, septotomy is performed only when an obstructive septum is identified; otherwise, standard LES myotomy alone suffices. This selective strategy, validated by outcomes from Facciorusso et al[17] and Wessels et al[19], minimizes unnecessary intervention while maintaining efficacy. Even when POEM is unsuccessful or contraindicated, surgical salvage options exist, including thoracoscopic diverticulectomy as reported by Yamashita et al[25] in patients who developed recurrent symptoms after initial endoscopic treatment.
Fourth, post-procedural care includes routine proton pump inhibitor prophylaxis to manage potential gastroesophageal reflux. Long-term monitoring beyond 6-12 months is essential, as a substantial proportion of post-POEM GERD is asymptomatic and detectable only on pH-impedance studies[13,14]. Scheduled follow-up should assess symptom relief (Eckardt score) and screen for reflux complications.
The evidence supporting morphology-guided POEM, while compelling, derives predominantly from retrospective series and meta-analyses. Prospective validation is needed, and we propose specific parameters for future investigation. A multicenter randomized controlled trial comparing selective septotomy against universal septotomy should include key endpoints such as: (1) Clinical success (Eckardt score ≤ 3) at 1, 2, and 5 years; (2) Septotomy-specific complication rates (mucosal perforation, bleeding); (3) Procedure duration; and (4) Post-procedural GERD incidence documented by routine pH-impedance studies. Alternatively, a large prospective registry with standardized septum phenotyping protocols could provide real-world effectiveness data while capturing the morphological variability that makes this condition challenging to study.
A particularly promising direction involves AI applied directly to the central decision point in our proposed strategy. Computer vision models trained on endoscopic images could provide real-time, objective classification of septum morphology during POEM, distinguishing obstructive from non-obstructive septa with greater consistency than human visual assessment alone. This would reduce inter-operator variability—a critical step toward standardizing the selective approach across centers. Early work in esophageal manometry interpretation has demonstrated the feasibility of such AI applications[26,27], and extending these techniques to endoscopic phenotyping represents a logical next step.
The evolution of diagnostic classification systems also has important implications for patient selection. The transition from Chicago Classification v3.0 to v4.0 has resulted in more stringent diagnostic criteria for esophagogastric junction outflow obstruction and ineffective esophageal motility[28,29]. For patients with achalasia and ED, accurate phenotypic classification using both high-resolution manometry and emerging technologies such as functional lumen imaging probe (FLIP) may provide complementary insights into esophageal wall properties that influence treatment outcomes[30]. FLIP can detect structural abnormalities—including hypertrophy or fibrosis—that may not be apparent on manometry alone, potentially identifying patients who might benefit from more extensive myotomy or adjunctive septotomy.
Additional technical refinements on the horizon include automated mucosal closure devices to streamline the procedure and endoscopic fundoplication techniques (e.g., transoral incisionless fundoplication) that may offer more durable GERD control than medical therapy alone. These innovations, combined with a robust evidence base for selective septotomy, will further cement morphology-guided POEM as the standard of care.
The management of achalasia with epiphrenic diverticulum has evolved from high-morbidity surgery to refined endoscopic precision. The morphology-guided POEM strategy—using real-time endoscopic anatomy to tailor therapy—effectively challenges the dogma of universal septotomy. It offers a smarter, safer, and equally effective path that embodies personalized care. As technology and prospective data further mature, this approach is poised to become the definitive standard, ensuring optimal outcomes for patients with this complex dual pathology.
| 1. | Hao XW, Bi YW, Wang ZM, Niu XT, Xiang JY, Su S, Li LS, Linghu EQ, Chai NL. Simultaneous treatment of concomitant achalasia coexisting with epiphrenic diverticulum: The practice of submucosal tunneling technique. World J Gastroenterol. 2026;32:114758. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 2. | Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG Clinical Guidelines: Diagnosis and Management of Achalasia. Am J Gastroenterol. 2020;115:1393-1411. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 397] [Cited by in RCA: 327] [Article Influence: 54.5] [Reference Citation Analysis (0)] |
| 3. | Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE; International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160-174. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1703] [Cited by in RCA: 1500] [Article Influence: 136.4] [Reference Citation Analysis (5)] |
| 4. | Nabi Z, Talukdar R, Chavan R, Basha J, Reddy DN. Outcomes of Per-Oral Endoscopic Myotomy in Children: A Systematic Review and Meta-analysis. Dysphagia. 2022;37:1468-1481. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 15] [Cited by in RCA: 14] [Article Influence: 3.5] [Reference Citation Analysis (0)] |
| 5. | Fisichella PM, Jalilvand A, Dobrowolsky A. Achalasia and epiphrenic diverticulum. World J Surg. 2015;39:1614-1619. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 20] [Cited by in RCA: 23] [Article Influence: 2.1] [Reference Citation Analysis (3)] |
| 6. | Costantini M, Zaninotto G, Guirroli E, Rizzetto C, Portale G, Ruol A, Nicoletti L, Ancona E. The laparoscopic Heller-Dor operation remains an effective treatment for esophageal achalasia at a minimum 6-year follow-up. Surg Endosc. 2005;19:345-351. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 89] [Cited by in RCA: 82] [Article Influence: 3.9] [Reference Citation Analysis (0)] |
| 7. | Soares R, Herbella FA, Prachand VN, Ferguson MK, Patti MG. Epiphrenic diverticulum of the esophagus. From pathophysiology to treatment. J Gastrointest Surg. 2010;14:2009-2015. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 98] [Cited by in RCA: 68] [Article Influence: 4.3] [Reference Citation Analysis (3)] |
| 8. | Portale G, Costantini M, Rizzetto C, Guirroli E, Ceolin M, Salvador R, Ancona E, Zaninotto G. Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: possible detrimental role of previous endoscopic treatment. J Gastrointest Surg. 2005;9:1332-1339. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 87] [Cited by in RCA: 75] [Article Influence: 3.6] [Reference Citation Analysis (0)] |
| 9. | Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42:265-271. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1502] [Cited by in RCA: 1278] [Article Influence: 79.9] [Reference Citation Analysis (10)] |
| 10. | Vigneswaran Y, Ujiki MB. Peroral endoscopic myotomy: An emerging minimally invasive procedure for achalasia. World J Gastrointest Endosc. 2015;7:1129-1134. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 6] [Cited by in RCA: 5] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
| 11. | Vespa E, Pellegatta G, Chandrasekar VT, Spadaccini M, Patel H, Maselli R, Galtieri PA, Carlani E, Sharma P, Hassan C, Repici A. Long-term outcomes of peroral endoscopic myotomy for achalasia: a systematic review and meta-analysis. Endoscopy. 2023;55:167-175. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 45] [Article Influence: 15.0] [Reference Citation Analysis (1)] |
| 12. | Calabrese EC, Kindel T, Slater BJ, Marks J, Swanstrom L, Saxena P, Docimo S, Athanasiadis DI, Hanna NM, Stefanidis D, Rooker C, Maddern G, Kohn GP. 2024 Update to SAGES guidelines for the use of peroral endoscopic myotomy (POEM) in the treatment of achalasia. Surg Endosc. 2025;39:4027-4037. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 10] [Cited by in RCA: 10] [Article Influence: 10.0] [Reference Citation Analysis (1)] |
| 13. | Repici A, Fuccio L, Maselli R, Mazza F, Correale L, Mandolesi D, Bellisario C, Sethi A, Khashab MA, Rösch T, Hassan C. GERD after per-oral endoscopic myotomy as compared with Heller's myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc. 2018;87:934-943.e18. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 251] [Cited by in RCA: 213] [Article Influence: 26.6] [Reference Citation Analysis (0)] |
| 14. | Familiari P, Greco S, Gigante G, Calì A, Boškoski I, Onder G, Perri V, Costamagna G. Gastroesophageal reflux disease after peroral endoscopic myotomy: Analysis of clinical, procedural and functional factors, associated with gastroesophageal reflux disease and esophagitis. Dig Endosc. 2016;28:33-41. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 101] [Cited by in RCA: 90] [Article Influence: 9.0] [Reference Citation Analysis (1)] |
| 15. | Kum AST, De Moura DTH, Proença IM, Aikawa M, Sánchez-Luna SA, Ribeiro IB, Sasso JGRJ Sr, Bestetti AM, Bernardo WM, Hourneaux de Moura EG. Gastroesophageal Reflux Waning Over Time in Endoscopic Versus Surgical Myotomy for the Treatment of Achalasia: A Systematic Review and Meta-Analysis. Cureus. 2022;14:e31756. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 3] [Reference Citation Analysis (0)] |
| 16. | Khaiser A, Baig M, Forcione D, Bechtold M, Puli SR. Efficacy and Safety of Peroral Endoscopic Myotomy (POEM) in Achalasia: An Updated Meta-analysis. Middle East J Dig Dis. 2023;15:235-241. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 5] [Reference Citation Analysis (0)] |
| 17. | Facciorusso A, Ramai D, Ichkhanian Y, Yadlapati R, Annese V, Wani S, Khashab MA. Peroral Endoscopic Myotomy for the Treatment of Esophageal Diverticula: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2022;56:853-862. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 21] [Cited by in RCA: 24] [Article Influence: 6.0] [Reference Citation Analysis (0)] |
| 18. | Shrigiriwar A, Mony S, Fayyaz F, Onimaru M, Monachese M, Zhang L, Corre F, Azmeera P, Wu H, Wu CCH, Choi K, Gandhi A, Chalikonda D, Keane MG, Ghandour B, Villamarin-Corrales J, Schlachterman A, Tinto RR, Arévalo FE, Arbizu EA, Bapaye A, Velanovich V, Nieto J, Pawa R, Pawa S, Samanta J, Sedarat A, Eleftheriadis N, Saxena P, Bechara R, Al-Haddad MA, Familiari P, Ujiki M, Ramchandani M, Barret M, Chang K, Moll F, Pioche M, Inoue H, Khashab M. Clinical outcomes of peroral endoscopic myotomy with and without septotomy for management of epiphrenic diverticula: an international multicenter experience (with video). Gastrointest Endosc. 2024;100:840-848.e4. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 8] [Cited by in RCA: 11] [Article Influence: 5.5] [Reference Citation Analysis (1)] |
| 19. | Wessels EM, Schuitenmaker JM, Bastiaansen BAJ, Fockens P, Masclee GMC, Bredenoord AJ. Efficacy and safety of peroral endoscopic myotomy for esophageal diverticula. Endosc Int Open. 2023;11:E546-E552. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 5] [Reference Citation Analysis (0)] |
| 20. | Rebecchi F, Giaccone C, Farinella E, Campaci R, Morino M. Randomized controlled trial of laparoscopic Heller myotomy plus Dor fundoplication versus Nissen fundoplication for achalasia: long-term results. Ann Surg. 2008;248:1023-1030. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 210] [Cited by in RCA: 158] [Article Influence: 8.8] [Reference Citation Analysis (0)] |
| 21. | Benacci JC, Deschamps C, Trastek VF, Allen MS, Daly RC, Pairolero PC. Epiphrenic diverticulum: results of surgical treatment. Ann Thorac Surg. 1993;55:1109-13; discussion 1114. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 149] [Cited by in RCA: 120] [Article Influence: 3.6] [Reference Citation Analysis (3)] |
| 22. | Miutescu BP, Khan S, Mony S, Khashab MA. Role of Peroral Endoscopic Myotomy (POEM) in the Management of Esophageal Diverticula. Clin Endosc. 2020;53:646-651. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 4] [Cited by in RCA: 10] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
| 23. | Ren L, Ye H, Zhu Y, Xie W, Liang Y, Liu Y, Dong J, Chen W, Chen X, Wang B, Pan L, Shi R. Diverticular peroral endoscopic myotomy (D-POEM) for symptomatic oesophageal diverticulum: a multicentre cohort study with a minimum follow-up of 3 years. Surg Endosc. 2024;38:253-259. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 7] [Cited by in RCA: 10] [Article Influence: 5.0] [Reference Citation Analysis (1)] |
| 24. | Wang M, Chen Y, Wang W. Combined Peroral Endoscopic Myotomy (POEM) and Diverticular POEM (D-POEM) for Type II Achalasia with a Large Epiphrenic Diverticulum. Dig Dis Sci. 2026;71:2636-2637. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 25. | Yamashita T, Otsuka K, Kohmoto M, Saito A, Kishimoto Y, Motegi K, Ariyoshi T, Goto S, Inoue H, Murakami M, Aoki T. Thoracoscopic Diverticulectomy for Epiphrenic Esophageal Diverticulum after Peroral Endoscopic Myotomy: A Report of Four Cases. Surg Case Rep. 2025;11:25-0065. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 26. | Mascarenhas M, Mota J, Rala Cordeiro J, Mendes F, Martins M, Cardoso P, Almeida MJ, Pinto da Costa A, Hajra Martinez I, Matallana Royo V, Niland B, Di Palma J, Ferreira J, Macedo G, Santander C. Artificial Intelligence Driven Diagnosis of Motility Patterns in High-Resolution Esophageal Manometry: A Multicentric Multidevice Study. Clin Transl Gastroenterol. 2025;16:e00941. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 2] [Cited by in RCA: 4] [Article Influence: 4.0] [Reference Citation Analysis (0)] |
| 27. | Gong EJ, Bang CS, Lee JJ, Baik GH. AI in Esophageal Motility Disorders: Systematic Review of High-Resolution Manometry Studies. J Med Internet Res. 2025;27:e85223. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 28. | Diab AR, El Naamani H, Sachdeva M, Adusmilli M, Docimo SJD, Sujka J, DuCoin C. S2273 GERD Following POEM: Is Endoscopic Fundoplication the Answer? A Meta-Analysis. Am J Gastroenterol. 2025;120:S488. [DOI] [Full Text] |
| 29. | Hamann KS, Mayer N, Kozak P, Kaplan M. S1063 Comparing Trends in Esophageal Motility Disorder Diagnoses Between the Chicago Classification v3.0 (CCv3.0) and the Chicago Classification v4.0 (CCv4.0) in a Community Hospital Setting. Am J Gastroenterol. 2025;120:S229-S229. [DOI] [Full Text] |
| 30. | Jung KW, Pandolfino JE. When Manometry and Functional Lumen Imaging Probe Disagree: The Current Limitations of the Chicago Classification Version 4.0 and Probable Extended Indications of Functional Lumen Imaging Probe. J Neurogastroenterol Motil. 2025;31:304-312. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 5] [Reference Citation Analysis (0)] |